Advertisement

PharmacoEconomics & Outcomes News

, Volume 813, Issue 1, pp 25–25 | Cite as

Rabbit antithymocyte globulin better choice in renal transplant

Clinical study
  • 9 Downloads

Reference

  1. Xuan D, et al. A Cost-Effectiveness Analysis of Rabbit Antithymocyte Globulin Versus Antithymocyte Globulin-Fresenius as Induction Therapy for Patients With Kidney Transplantation From Donation After Cardiac Death in China. Clinical Therapeutics : 20 Sep 2018. Available from: URL: http://doi.org/10.1016/j.clinthera.2018.08.017

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations